title: Repeated peptide receptor radiotherapy in multiple recurrences of a metastasized neuroendocrine tumor.
authors.forename: Claudia
authors.initials: C
authors.lastname: Brogsitter
authors.forename: Klaus
authors.initials: K
authors.lastname: Zöphel
authors.forename: Gunnar
authors.initials: G
authors.lastname: Folprecht
authors.forename: Grame
authors.initials: G
authors.lastname: Eisenhofer
authors.forename: Jörg
authors.initials: J
authors.lastname: Kotzerke
mesh_terms: D005260:Female; D006801:Humans; D007414:Intestinal Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy*; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy*; D018358:Neuroendocrine Tumors / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy*; D015282:Octreotide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009942:Organometallic Compounds / Q000627:therapeutic use*; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy*; D000072078:Positron Emission Tomography Computed Tomography; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D019275:Radiopharmaceuticals / Q000627:therapeutic use*; D013274:Stomach Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy*
chemical_list: C499142:Ga(III)-DOTATOC; D009942:Organometallic Compounds; D047428:Protein Kinase Inhibitors; D019275:Radiopharmaceuticals; C496730:90Y-octreotide, DOTA-Tyr(3)-; C447941:lutetium Lu 177 dotatate; D015282:Octreotide